DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,122 filers reported holding DANAHER CORPORATION in Q2 2024. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,191,784 | +82.2% | 4,770 | +82.1% | 0.76% | +74.1% |
| Q1 2024 | $654,017 | +8.5% | 2,619 | +0.5% | 0.44% | +0.9% |
| Q4 2023 | $602,641 | -8.4% | 2,605 | -1.8% | 0.43% | -13.2% |
| Q3 2023 | $657,961 | +6.3% | 2,652 | +2.8% | 0.50% | +10.4% |
| Q2 2023 | $619,200 | -3.0% | 2,580 | +1.8% | 0.45% | -10.8% |
| Q1 2023 | $638,669 | -1.1% | 2,534 | +4.2% | 0.51% | -7.3% |
| Q4 2022 | $645,501 | +3.0% | 2,432 | +0.2% | 0.55% | +9.4% |
| Q3 2022 | $627,000 | +11.4% | 2,427 | +9.3% | 0.50% | +19.3% |
| Q2 2022 | $563,000 | -13.4% | 2,221 | +0.2% | 0.42% | +10.6% |
| Q1 2022 | $650,000 | -38.6% | 2,216 | -31.1% | 0.38% | -37.1% |
| Q4 2021 | $1,058,000 | +6.5% | 3,216 | -1.4% | 0.60% | +8.3% |
| Q3 2021 | $993,000 | +14.3% | 3,263 | +0.7% | 0.56% | +23.8% |
| Q2 2021 | $869,000 | +23.4% | 3,239 | +3.6% | 0.45% | +28.9% |
| Q1 2021 | $704,000 | +68.8% | 3,126 | +78.3% | 0.35% | +154.7% |
| Q4 2020 | $417,000 | +38.5% | 1,753 | +25.5% | 0.14% | +7.0% |
| Q3 2020 | $301,000 | +31.4% | 1,397 | +8.0% | 0.13% | +7.6% |
| Q2 2020 | $229,000 | – | 1,293 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |